PHAZE 7 PROTECTING HYDRATOR SPF 15 (produit inactif : annulé (notification annuelle omise) : 4 avril 2018)

Nonprescription drug in Canada (DIN); Status not published: 4 April 2018

DIN

02237231

Trade name

PHAZE 7 PROTECTING HYDRATOR SPF 15

Company

PHYSICIAN'S CHOICE OF ARIZONA, INC.

Current status

Status not published: 4 April 2018

Product update in the source

22 March 2025

Form

Lotion

Routes

Topique

ATC classes

D02BA30 : French label not published

Status history

• Approved: 21 January 1998
• Status not published: 4 April 2018; current status

Published active ingredients and strengths

Mass/volume percentages are not treated as mass/mass percentages. A strength expressed as base is not converted to the strength of the salt or compound.

Cosmetic analysis in the European Union

• OCTINOXATE : Filtre UV autorisé sous les conditions de l’annexe VI du règlement (CE) 1223/2009.
  • Annexe VI, entrée 12 : 10 % ; comparaison de teneur non établie sans estimation.
• TITANIUM DIOXIDE : Filtre UV autorisé sous les conditions de l’annexe VI du règlement (CE) 1223/2009.
  • Annexe III, entrée 321 : (a) 25 %; (b) 1,4 % for general consu­mers, and 1,1 % for pro­fessional use. ; seulement pour : (a) face products in loose powder form (b) hair aerosol spray pro­ducts (c) other products ; a) (b) Only in the pigmentary form (c) Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation ; comparaison de teneur non établie sans estimation.
  • Annexe VI, entrée 27 : 25 %* *: In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g (Maximum concen­tration in ready for use preparation) ; Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321. For the product types under letter (c) of column (f) in Annex III, No 321, the maximum concentration in ready for use preparation provided in column (g) of this entry applies. (For use as a colourant, see Annex IV, No 143) ; comparaison de teneur non établie sans estimation.
• OXYBENZONE : Filtre UV autorisé sous les conditions de l’annexe VI du règlement (CE) 1223/2009.
  • Annexe VI, entrée 4 : a) 6 % b) 2,2 % c) 0,5 % Footnote 1: However, cosmetic products containing '2-Hydroxy-4-methoxy-benzophenone/Oxybenzone' and complying with the restrictions set out in Regulation (EC) No 1223/2009 as applicable on 27 July 2022 may be placed on the Union market until 28 January 2023 and be made available on the Union market until 28 July 2023. ; seulement pour : a) Face products, hand products, and lip products, excluding propellant and pump spray products b) Body products, including propellant and pump spray products c) Other products ; a) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 5,5 %. b) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 1,7 %. ; comparaison de teneur non établie sans estimation.

3 ingredients allowed under conditions (maximum concentration, product types): some active ingredient concentrations are printed; the other conditions and the product's classification in the European Union remain to be checked. 3 names recognised out of 3.

ETHYLHEXYL METHOXYCINNAMATE, TITANIUM DIOXIDE, BENZOPHENONE-3

Who it concerns

For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.

Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.

• Read on the label

  • For information BENZOPHENONE-3Annex VI, entry 4, requires this to be printed on the pack: “For a) and b): Contains Benzophenone-3 (*) Footnote (*): Not required if concentration is 0,5 % or less and when it is used only for product protection purposes.”.

No official text covers the recognised ingredients for: pregnancy and breastfeeding, babies and children, skin, eyes and allergies, environment.

For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.

Selling elsewhere

Ingredients of this list that are prohibited, prohibited in some cases or subject to conditions in the other countries whose rules we record (nothing changes for sale in France). Absence is not approval: several countries only allow the preservatives, UV filters and colorants on their lists, and the function of an ingredient in the product is not known. What is covered for each country.

No prohibition or condition found in the recorded lists for: United States (federal), Washington State, California, Canada, Japan, China.

Ingredient by ingredient

The line under each name gives its rule in the European Union (legend below). Click a name for its page.

Hover over or tap a badge for its meaning.

Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.

Official Drug Product Database record.

Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPP).

All Canadian nonprescription drugs resembling cosmetics